US 7527791
Prior Art
How Engineered Antibodies Target TGF-beta Proteins to Fight Cancer
Patents that US 7527791 cites as prior art — the earlier inventions that this patent builds upon or distinguishes itself from.
CITED PATENTS
215
IN PATENTLENS
0
Citation data
This patent cites 215 prior patents. Citation detail pages are being built out in Phase 2.
Prior art citations are sourced from the USPTO patent database. Only patents indexed in PatentBrief are shown as links — others are recorded by number only.